{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:19:54Z","timestamp":1770009594360,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.7759\/cureus.100597","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:16:38Z","timestamp":1767345398000},"source":"Crossref","is-referenced-by-count":1,"title":["A Highly Uncommon Presentation: A Consecutive Three-Case Series of Malignant Ureteral Obstruction in Long-Term Survivors of Non-small Cell Lung Cancer"],"prefix":"10.7759","author":[{"given":"Tomoyuki","family":"Araya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazuki","family":"Takato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000181807.56114.b7","article-title":"The management of malignant ureteral obstruction treated with ureteral stents","volume":"174","author":"Ganatra AM","year":"2005","unstructured":"Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents. J Urol. 2005, 174:2125-8. 10.1097\/01.ju.0000181807.56114.b7","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.09.102","article-title":"Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction","volume":"185","author":"Izumi K","year":"2011","unstructured":"Izumi K, Mizokami A, Maeda Y, Koh E, Namiki M. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Urol. 2011, 185:556-61. 10.1016\/j.juro.2010.09.102","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.04.008","article-title":"Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes","volume":"180","author":"Kouba E","year":"2008","unstructured":"Kouba E, Wallen EM, Pruthi RS. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. J Urol. 2008, 180:444-50. 10.1016\/j.juro.2008.04.008","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12963","article-title":"A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients","volume":"117","author":"Cordeiro MD","year":"2016","unstructured":"Cordeiro MD, Coelho RF, Chade DC, et al.. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients. BJU Int. 2016, 117:266-71. 10.1111\/bju.12963","journal-title":"BJU Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21390","article-title":"Lung cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Rami-Porta R","year":"2017","unstructured":"Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017, 67:138-55. 10.3322\/caac.21390","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2020.1724094","article-title":"A profile on cobas\u00ae EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer","volume":"20","author":"Torres S","year":"2020","unstructured":"Torres S, Gonz\u00e1lez \u00c1, Cunquero Tomas AJ, et al.. A profile on cobas\u00ae EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer. Expert Rev Mol Diagn. 2020, 20:575-82. 10.1080\/14737159.2020.1724094","journal-title":"Expert Rev Mol Diagn"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183023","article-title":"Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms","volume":"12","author":"Ilie M","year":"2017","unstructured":"Ilie M, Khambata-Ford S, Copie-Bergman C, Huang L, Juco J, Hofman V, Hofman P. Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms. PLoS One. 2017, 12:e0183023. 10.1371\/journal.pone.0183023","journal-title":"PLoS One"},{"key":"ref8","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55.","journal-title":"Am J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15176","article-title":"Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L","volume":"113","author":"Sakata S","year":"2022","unstructured":"Sakata S, Otsubo K, Yoshida H, et al.. Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L. Cancer Sci. 2022, 113:221-8. 10.1111\/cas.15176","journal-title":"Cancer Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.97093","article-title":"Tumor-to-tumor metastasis of epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma to a meningioma 14 years after curative lobectomy: a case report","volume":"17","author":"Yoneda T","year":"2025","unstructured":"Yoneda T, Araya T, Higashi T, Hara R, Kita T. Tumor-to-tumor metastasis of epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma to a meningioma 14 years after curative lobectomy: a case report. Cureus. 2025, 17:e97093. 10.7759\/cureus.97093","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04803-x","article-title":"Malignant ureteral obstruction: comparison of metallic, 8 French and 6 French ureteric stents after failure of initial ureteric stent","volume":"42","author":"Ong K","year":"2024","unstructured":"Ong K, Chen J, Kong J, Kuan M. Malignant ureteral obstruction: comparison of metallic, 8 French and 6 French ureteric stents after failure of initial ureteric stent. World J Urol. 2024, 42:92. 10.1007\/s00345-024-04803-x","journal-title":"World J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-019-1608-6","article-title":"Malignant ureteral obstruction: experience and comparative analysis of metallic versus ordinary polymer ureteral stents","volume":"17","author":"Chen Y","year":"2019","unstructured":"Chen Y, Liu CY, Zhang ZH, et al.. Malignant ureteral obstruction: experience and comparative analysis of metallic versus ordinary polymer ureteral stents. World J Surg Oncol. 2019, 17:74. 10.1186\/s12957-019-1608-6","journal-title":"World J Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84072","article-title":"Safety and efficacy of double-J metallic mesh ureteral stents in malignant ureteral obstruction","volume":"17","author":"Nonoyama S","year":"2025","unstructured":"Nonoyama S, Furumido J, Kato R, Ozaki N, Matsugase Y. Safety and efficacy of double-J metallic mesh ureteral stents in malignant ureteral obstruction. Cureus. 2025, 17:e84072. 10.7759\/cureus.84072","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2021.02.016","article-title":"Comparison of a covered metallic ureteral stent and a double-J stent for malignant ureteral obstruction in advanced gastric cancer","volume":"76","author":"Kim ET","year":"2021","unstructured":"Kim ET, Yang WJ, Shin JH, Cho SJ, Song SY, Song MG, Kang D. Comparison of a covered metallic ureteral stent and a double-J stent for malignant ureteral obstruction in advanced gastric cancer. Clin Radiol. 2021, 76:519-25. 10.1016\/j.crad.2021.02.016","journal-title":"Clin Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/449257-a-highly-uncommon-presentation-a-consecutive-three-case-series-of-malignant-ureteral-obstruction-in-long-term-survivors-of-non-small-cell-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:16:39Z","timestamp":1767345399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/449257-a-highly-uncommon-presentation-a-consecutive-three-case-series-of-malignant-ureteral-obstruction-in-long-term-survivors-of-non-small-cell-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.100597","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}